AC
IONS icon

Alexandria Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Alexandria Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$616K Buy
18,362
+65
+0.4% +$2.45K 0.06% 175
2021
Q2 		$730K Buy
18,297
+535
+3% +$21K 0.07% 168
2021
Q1 		$799K Sell
17,762
-30
-0.2% -$1.67K 0.08% 159
2020
Q4 		$1.01M Sell
17,792
-202
-1% -$10.1K 0.11% 142
2020
Q3 		$854K Hold
17,994
– – 0.1% 145
2020
Q2 		$1.06M Buy
17,994
+86
+0.5% +$4.78K 0.14% 134
2020
Q1 		$847K Sell
17,908
-735
-4% -$41K 0.14% 134
2019
Q4 		$1.13M Hold
18,643
– – 0.15% 130
2019
Q3 		$1.12M Sell
18,643
-612
-3% -$39.9K 0.17% 126
2019
Q2 		$1.24M Sell
19,255
-3
-0% -$212 0.18% 131
2019
Q1 		$1.56M Buy
19,258
+98
+0.5% +$6.32K 0.23% 119
2018
Q4 		$1.04M Hold
19,160
– – 0.17% 134
2018
Q3 		$989K Hold
19,160
– – 0.15% 133
2018
Q2 		$799K Hold
19,160
– – 0.12% 143
2018
Q1 		$845K Buy
19,160
+50
+0.3% +$2.54K 0.13% 141
2017
Q4 		$962K Buy
19,110
+19,098
+159,150% +$1.05M 0.14% 137
2017
Q3 		$1K Sell
12
-7
-37% -$367 ﹤0.01% 529
2017
Q2 		$1K Hold
19
– – ﹤0.01% 587
2017
Q1 		$1K Hold
19
– – ﹤0.01% 582
2016
Q4 		$1K Buy
19
+2
+12% +$79 ﹤0.01% 562
2016
Q3 		$1K Buy
17
+8
+89% +$250 ﹤0.01% 573
2016
Q2 		$0 Buy
+9
New +$290 ﹤0.01% 630
2013
Q4 		– Sell
-10,000
Closed -$375K – 607
2013
Q3 		$375K Hold
10,000
– – 0.17% 69
2013
Q2 		$269K Buy
+10,000
New +$213K 0.13% 85

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alexandria Capital's IONS Position: Q3 2021 in Review

Alexandria Capital increased its Ionis Pharmaceuticals (IONS) stake by 0.36% in Q3 2021, buying an estimated $2.45K and bringing the position to 18,362 shares worth $616K. The position accounts for 0.06% of the portfolio, ranked #175.

Alexandria Capital first reported a position in IONS in Q2 2013 and has held it in 24 quarters since. The position peaked at $1.56M in Q1 2019. 325 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • Alexandria Capital held 18,362 shares of Ionis Pharmaceuticals worth $616K as of Q3 2021.
  • Alexandria Capital bought 65 Ionis Pharmaceuticals shares in Q3 2021, an estimated $2.45K.
  • Ionis Pharmaceuticals made up 0.06% of Alexandria Capital's portfolio in Q3 2021, its #175 holding.
  • Alexandria Capital first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
  • Alexandria Capital's Ionis Pharmaceuticals position peaked at $1.56M in Q1 2019.
  • 325 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.